Litcius/Paper detail

Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect”

Maria Adriana Cataldo, Nardi Tetaj, Marina Selleri, Luisa Marchioni, Alessandro Capone, Emanuela Caraffa, Antonino Di, Nicola Petrosillo

2020Journal of Global Antimicrobial Resistance89 citationsDOIOpen Access PDF

Abstract

• COVID-19 patients have an exaggerated risk of acquiring BSI during ICU stay. • The incidence of ICU-acquired BSI in COVID-19 patients is higher than that reported in European ICUs in the pre-COVID-19 period. • The commonest aetiological agents of BSI were intestinal commensals. • A high rate of acquisition of VRE colonisation was observed.

Topics & Concepts

Incidence (geometry)MedicineCoronavirus disease 2019 (COVID-19)ColonisationEtiologyBloodstream infectionIntensive careIntensive care medicineInternal medicineMicrobiologyColonizationDiseaseBiologyInfectious disease (medical specialty)OpticsPhysicsAntibiotic Use and ResistanceNosocomial Infections in ICUAntibiotic Resistance in Bacteria
Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming “collateral effect” | Litcius